GSK is one of only 25 US companies currently accredited by the CEO Cancer Gold Standard
The CEO Cancer Gold Standard is a workplace initiative that combats cancer by focusing on three objectives: risk reduction, early detection and quality care. This aligns closely with GSK’s Triple Message of 1) prevention, 2) intervention in chronic disease, and 3) innovation to improve health.
Announcements
Recent headlines
[an error occurred while processing this directive]
[an error occurred while processing this directive]
December 23, 2008
Cytokinetics retains development and commercialization rights to ispinesib and SB-743921
December 23, 2008
GlaxoSmithKline and Archemix form strategic alliance to develop aptamers to treat inflammatory diseases
December 22, 2008
GlaxoSmithKline to cease providing corporate political contributions
GSK News Services
Leading the way to make clinical trial data more transparent
Learn about flu treatment
Find health information
Save money on your prescriptions
Join GSK
Updated December 23, 2008
© 2001 - 2009 GlaxoSmithKline - All rights reserved